Bifogade filer
Kurs
+1,33%
Kalender
Est. tid* | ||
2025-02-21 | - | Bokslutskommuniké 2024 |
2024-11-22 | - | Kvartalsrapport 2024-Q3 |
2024-10-01 | - | 15-6 2024 |
2024-08-30 | - | Kvartalsrapport 2024-Q2 |
2024-06-25 | - | Årsstämma |
2024-05-29 | - | X-dag ordinarie utdelning CHRO 0.00 SEK |
2024-05-23 | - | Kvartalsrapport 2024-Q1 |
2024-04-05 | - | Extra Bolagsstämma 2024 |
2024-03-08 | - | Bokslutskommuniké 2023 |
2023-11-30 | - | Kvartalsrapport 2023-Q3 |
2023-09-11 | - | Split CHRO 100:1 |
2023-08-25 | - | Kvartalsrapport 2023-Q2 |
2023-06-21 | - | Årsstämma |
2023-05-26 | - | X-dag ordinarie utdelning CHRO 0.00 SEK |
2023-05-25 | - | Kvartalsrapport 2023-Q1 |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-11-18 | - | Kvartalsrapport 2022-Q3 |
2022-11-08 | - | Extra Bolagsstämma 2022 |
2022-08-25 | - | Kvartalsrapport 2022-Q2 |
2022-05-20 | - | X-dag ordinarie utdelning CHRO 0.00 SEK |
2022-05-19 | - | Årsstämma |
2022-05-19 | - | Kvartalsrapport 2022-Q1 |
2022-02-18 | - | Bokslutskommuniké 2021 |
2021-11-19 | - | Kvartalsrapport 2021-Q3 |
2021-08-26 | - | Kvartalsrapport 2021-Q2 |
2021-05-21 | - | X-dag ordinarie utdelning CHRO 0.00 SEK |
2021-05-20 | - | Årsstämma |
2021-05-20 | - | Kvartalsrapport 2021-Q1 |
2021-02-19 | - | Bokslutskommuniké 2020 |
2020-11-13 | - | Kvartalsrapport 2020-Q3 |
2020-08-27 | - | Kvartalsrapport 2020-Q2 |
2020-08-17 | - | Split CHRO 100:1 |
2020-05-15 | - | X-dag ordinarie utdelning CHRO 0.00 SEK |
2020-05-14 | - | Årsstämma |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-02-21 | - | Bokslutskommuniké 2019 |
2019-12-18 | - | Extra Bolagsstämma 2019 |
2019-05-16 | - | X-dag ordinarie utdelning CHRO 0.00 SEK |
2019-05-15 | - | Årsstämma |
2019-02-28 | - | Bokslutskommuniké 2018 |
2018-10-26 | - | Kvartalsrapport 2018-Q3 |
2018-07-20 | - | Kvartalsrapport 2018-Q2 |
2018-05-17 | - | X-dag ordinarie utdelning CHRO 0.00 SEK |
2018-05-16 | - | Årsstämma |
2018-04-27 | - | Kvartalsrapport 2018-Q1 |
2018-02-23 | - | Bokslutskommuniké 2017 |
2017-12-15 | - | Extra Bolagsstämma 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-07-21 | - | Kvartalsrapport 2017-Q2 |
2017-05-11 | - | X-dag ordinarie utdelning CHRO 0.00 SEK |
2017-05-10 | - | Årsstämma |
2017-04-28 | - | Kvartalsrapport 2017-Q1 |
Beskrivning
Land | Sverige |
---|---|
Sektor | Industri |
Industri | Industriprodukter |
ChromoGenics and SECM in France have signed an agreement regarding manufacturing, marketing and distribution of the dynamic glass ConverLight® Dynamic. SECM has strong experience of sales and marketing of dynamic glass and is a quality manufacturer of laminated glass solutions.
Located in Rumilly, France, close to the Swiss border, SECM is an innovative and technologically advanced manufacturer and supplier of glass solutions for customers in the construction industry in France, Switzerland and other countries. SECM has extensive experience of sales and marketing of dynamic glass solutions and strong local market knowledge. SECM will in due course laminate ChromoGenics' electrochromic foil into finished products and has a capacity of 30,000 m2 laminated glass per year.
"This agreement is in line with our strategy to partner with high quality companies in the glass industry, allowing us to focus more on our core competence, i.e., the production and development of electrochromic foil. France and Switzerland are important markets for dynamic glass and we look forward to leverage SECM's strong market knowledge and experience in glass lamination." says Fredrik Fränding, CEO of ChromoGenics.
Fredrik Fränding, CEO
Erik Elfström, CFO & Head of Investor Relations
Tel: +46 (0) 18 430 0430
E-mail: info@chromogenics.com
SECM:
Pascal SOULIÉ, Président Délégué
Phone: +33 (0)6 80 65 61 06
E-mail: pascal.soulile@secm.fr
Sandrine RONDEPIERRE, Chargée d'Affaires
Phone: +33 (0) 6 28 83 92 16
E-mail: sandrine.rondepierre@secm.fr
More about SECM: SECM (http://www.secm.fr)
This statement has been made in a Swedish and English version. In the event of any discrepancies between the Swedish and English text, the Swedish text shall prevail.